IMARC Group's report titled "Organ Preservation Market Report by Preservation Solution (UW Solution, Custodiol HTK, Perfadex, and Others), Organ Donation Type (Living Organ Donation, Deceased Organ Donation), Technique (Static Cold Storage Technique, Hypothermic Machine Perfusion, Normothermic Machine Perfusion, and Others), Organ Type (Kidney, Liver, Lung, Heart, and Others), End-User (Hospitals and Clinics, Organ Banks, and Others), and Region 2024-2032", The global organ preservation market size reached US$ 187.9 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 313.4 Million by 2032, exhibiting a growth rate (CAGR) of 5.7% during 2024-2032.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/organ-preservation-market/requestsample
Factors Affecting the Growth of the Organ Preservation Industry:
- Increasing Organ Transplant Procedures:
As the number of organ transplant procedures is rising, the demand for effective organ preservation solutions is also increasing. These solutions are crucial for maintaining the viability and functionality of organs from the donor to the recipient, ensuring successful transplantation outcomes. Organ preservation techniques help extend the viability of organs outside the body, allowing for longer storage times and facilitating organ transportation from donor to recipient. Furthermore, the growing number of organ transplant procedures often corresponds to the expansion of transplantation programs in healthcare facilities worldwide. This expansion creates a larger market for organ preservation products and services as transplant centers seek advanced solutions to enhance their transplant programs.
- Technological Advancements:
Continuous technological innovations are leading to the development of more sophisticated organ preservation techniques and solutions. These advancements help improve organ viability during storage and transportation, increasing the likelihood of successful transplant procedures. Moreover, ongoing research and development (R&D) activities in the creation of novel organ preservation methods that offer improved outcomes compared to traditional techniques. This includes advancements in hypothermic and normothermic preservation, machine perfusion technologies, and cryopreservation techniques. In line with this, advancements in technology enable the creation of preservation solutions with enhanced properties, such as better osmotic balance, reduced toxicity, and improved cell protection mechanisms.
- Rising Healthcare Expenditure:
Increasing healthcare expenditure allows healthcare facilities to invest in advanced organ preservation technologies and solutions. Hospitals and transplant centers can allocate resources toward acquiring state-of-the-art preservation devices, equipment, and supplies, enabling them to offer high-quality organ preservation services to patients. Additionally, higher healthcare expenditures are leading to the expansion and modernization of healthcare infrastructure, including transplant centers and organ procurement organizations. This expansion creates opportunities for the adoption of advanced organ preservation techniques and the establishment of specialized facilities dedicated to organ preservation and transplantation.
Leading Companies Operating in the Global Organ Preservation Industry:
- 21st Century Medicine
- Biolife Solutions
- Bridge to Life Ltd.
- Bristol-Myers Squibb
- Dr. Franz Köhler Chemie GmbH
- Essential Pharmaceuticals.
- Lifeline Scientific
- OrganOx
- Paragonix Technologies
- TransMedics, Waters Medical Systems
- Xvivo Perfusion
Organ Preservation Market Report Segmentation:
By Preservation Solution:
- UW Solution
- Custodiol HTK
- Perfadex
- Others
UW solution represents the largest segment due to its exceptional ability to preserve organs during transplantation procedures.
By Organ Donation Type:
- Living Organ Donation
- Deceased Organ Donation
Deceased organ donation accounts for the majority of the market share as the prevalence of organ failure and chronic diseases necessitates a steady supply of transplantable organs.
By Technique:
- Static Cold Storage Technique
- Hypothermic Machine Perfusion
- Normothermic Machine Perfusion
- Others
Static cold storage technique holds the biggest market share owing to its proven effectiveness, simplicity, and widespread adoption.
By Organ Type:
- Kidney
- Liver
- Lung
- Heart
- Others
Kidney accounts for the leading segment, driven by the rising prevalence of end-stage renal disease and chronic kidney conditions worldwide.
By End-User:
- Hospitals and Clinics
- Organ Banks
- Others
Organ banks hold the largest market share as these institutions serve as centralized hubs for storing, matching, and distributing organs to patients in need.
Regional Insights:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
North America enjoys the leading position in the organ preservation market on account of advanced healthcare infrastructure and extensive research and development (R&D) activities.
Global Organ Preservation Market Trends:
The growing awareness among individuals about environmental issues is driving the demand for eco-friendly alternatives in healthcare. Sustainable preservation solutions, which utilize biodegradable materials and minimize environmental impact, align with these concerns and appeal to environmentally conscious healthcare providers and patients.
Additionally, rising collaborations between industry stakeholders, academic institutions, and environmental organizations can accelerate the development and adoption of sustainable preservation solutions. Collaborative efforts facilitate knowledge sharing, resource pooling, and collective action towards sustainability goals in organ preservation.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163